Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2019-11-26

Clinical Trial Update: CATS Tonometer IOP Reduction Latanoprost Verses Timolol [Phase 4]

View source ↗

Summary

Phase 4 trial comparing CATS tonometer IOP reduction using Latanoprost versus Timolol in glaucoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Latanoprost (Latanoprost)
  • Timolol (timolol)

Snippet

Sponsor: Intuor Technologies, Inc. | Conditions: Glaucoma; Drugs | Phase 4 | Status: UNKNOWN